{"id":8089,"name":"YZR Capital","slug":"yzr-capital","website":"https://yzr-capital.com/","hqGeo":null,"stageFocus":[],"sectorTags":[],"excludedSectors":[],"checkSizeMin":null,"checkSizeMax":null,"thesisSummary":null,"thesisNarrative":null,"logoUrl":null,"aumUsd":null,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"AI Platform for Chronic Disease Detection","companyUrl":null,"stage":null,"sector":"Innovating Value Chains","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Roclub","companyUrl":null,"stage":null,"sector":"Increase of Provider Efficiency","investmentYear":null,"description":"Teleoperation Platform for MedTech","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Doctor.One","companyUrl":null,"stage":null,"sector":"Innovating Value Chains","investmentYear":null,"description":"Identification of chronic care paths","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Scan.com","companyUrl":null,"stage":null,"sector":"Improvement of Patient Care","investmentYear":null,"description":"Medical imaging marketplace","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Biorce","companyUrl":null,"stage":null,"sector":"Innovating Value Chains","investmentYear":null,"description":"Faster and smarter drug development","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Filu","companyUrl":null,"stage":null,"sector":"Improvement of Patient Care","investmentYear":null,"description":"Tech-enabled veterinary clinic chain","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Deepeye Medical","companyUrl":null,"stage":null,"sector":"Increase of Provider Efficiency","investmentYear":null,"description":"Treatment support system for retinal diseases","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Deeplife","companyUrl":null,"stage":null,"sector":"Innovating Value Chains","investmentYear":null,"description":"Uncovers therapies for diseases with significant unmet needs and improves drug development","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"OpenHealth Technologies","companyUrl":null,"stage":null,"sector":"Increase of Provider Efficiency","investmentYear":null,"description":"Lab data harmonization platform","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"DaphOS","companyUrl":null,"stage":null,"sector":"Increase of Provider Efficiency","investmentYear":null,"description":"AI-driven resource management in healthcare.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ima Health","companyUrl":null,"stage":null,"sector":"Improvement of Patient Care","investmentYear":null,"description":"Medication-as-a-Service for polypharmacy patients","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"apoQlar","companyUrl":null,"stage":null,"sector":"Improvement of Patient Care","investmentYear":null,"description":"Powering the future of healthcare with mixed reality","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"dehaze","companyUrl":null,"stage":"Not specified","sector":"Health tech / AI diagnostics","investmentYear":null,"description":"AI platform for chronic disease detection.","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":5,"partners":[{"id":23408,"name":"Prof. Dr. Reinhard Meier","title":"General Partner","seniority":"partner","focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":23411,"name":"Holger Ebersberger","title":"Partner","seniority":"partner","focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":23410,"name":"Urs Keller","title":"Partner","seniority":"partner","focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":23409,"name":"Markus Feuerecker","title":"General Partner","seniority":"partner","focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":23412,"name":"Dr. Martina Samwer","title":"Partner","seniority":"partner","focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsThisYear":0},"activityItems":[{"kind":"news","title":"Vitroscope raises $7M to turn living human tissue into a new source of drug discovery data","url":"https://tech.eu/2026/11/03/vitroscope-raises-7m-to-turn-living-human-tissue-into-a-new-source-of-drug-discovery-data/","source":"Tech.eu","occurredAt":"2026-11-03T00:00:00.000Z"}],"contentUpdatedAt":"2026-11-14T13:29:22.991Z","investorType":"vc","preferredApproach":null,"prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[],"featuredIn":[],"fundraisingResources":[{"slug":"how-to-find-investors","title":"How to Find Investors: A VC's Playbook for Founders"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"},{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"}],"overviewNarrative":"YZR Capital is a venture capital firm focused on investments in health technology. The firm backs companies developing solutions across multiple areas of healthcare innovation.\n\nIts team consists of Prof. Dr. Reinhard Meier, Holger Ebersberger, Urs Keller, Markus Feuerecker, and Dr. Martina Samwer. The partners collectively support portfolio companies working on technologies that address chronic disease detection, patient care improvement, provider efficiency, and value chain innovation in healthcare.","portfolioNarrative":"YZR Capital has recorded investments in 13 portfolio companies. These investments include AI Platform for Chronic Disease Detection, apoQlar, Biorce, DaphOS, Deepeye Medical, Deeplife, dehaze, Doctor.One, Filu, Ima Health, OpenHealth Technologies, Roclub, and Scan.com.\n\nThe companies operate in sectors such as innovating value chains, improvement of patient care, increase of provider efficiency, and health tech or AI diagnostics. Investment stages are not specified in the firm's recorded data.","seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-07-13T14:42:12.126Z"}